Advanced Biomed Inc. Common Stock (ADVB)

Health Care·equity
$5.31
-13.24% today
Extended hours $5.21
Prices delayed about 15 minutes · cached page, can be an hour old or more
Market Census Score
36/ 100
Score level
Below average
6 of 6 checks had data

Smart-money score is below the middle — price trend score is below the middle.

ADVB scores higher than 43% of the 1,101 tickers we compare it with (Health Care).

As of 9 October 2026, Advanced Biomed Inc. Common Stock (ADVB) scores 36 out of 100 on the Market Census six-factor composite, which puts it at the Below average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 9 October 2026, and it is not investment advice.

Updated · scores usually change about once a day

TrendStrengthFinancialsInsidersMarketMomentum36/ 100

Key statistics

Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.

Relative volume
0.14× 30-day average
52-week range
3.61 – 24.23
Market cap
$10.80M
Earnings date
17 Nov 2026
Volume
8,803
Avg. volume (30d)
63,785
Open
6.07
Previous close
6.12
Day's range (regular session)
5.31 – 6.07

The last trade can be an extended-hours trade, so it can sit outside the regular-session range.

Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.

Beta
0.10
P/E (TTM)
2.94
EPS (TTM)
4.95

Score breakdown · six named factors

Price trend
25
Strength vs the market
52
Company finances
48
Insider trades
10
Market mood
50
Recent momentum
33

Each bar is one part of the score, from 0 to 100. Read what the score means.

Premium data held for ADVB

  • 2 SEC Form 4 insider transactions in the last 90 daysPremium

Counts of rows Market Census holds for ADVB. A dash in the factor table above means that factor has no data for this ticker — it is not a locked value. Compare plans

What the score says about ADVB right now

Advanced Biomed Inc. Common Stock (ADVB) currently scores 36/100 on the Market Census six-factor composite, at the Below average score level. ADVB is -13.24% on the day and -21.10% over five sessions as of the most recent tick. Below average sits a bit below the middle. More of ADVB's data reads poorly than well. The level is a "look before you act" flag. It is not advice. ADVB's strongest factor is strength vs the market at 52/100 — a fairly good read on how ADVB has done next to the wider market. It describes what has happened, not what happens next. The weakest factor is insider trades at 10/100 — a well below average read on insider buying and selling. Insider filings for ADVB lean toward selling; on a thinly filed name a few filings can set this reading.

Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.

See ADVB in the scanner

This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).

Recent ADVB news

Latest headlines that name Advanced Biomed, one per story, sourced from Market Census’s news feed (Polygon/Massive + Finnhub).

Saved snapshot; the news and prices on this page can be an hour old or more.

Similar setups in Health Care right now

Six health care tickers whose composite scores are closest to ADVB’s 36, all within 1 point.

Sorted by closeness to ADVB’s composite score within Health Care. Saved snapshot; can be an hour old or more. Run the full scanner →

Prices delayed about 15 minutes; scores usually change about once a day. Not investment advice — see risk disclosure.